NL-OMON43113尚未招募不适用
ong-term follow-up after Instrumented Bone Preserving (IBP) total elbow arthroplasty using RadioStereometric Analysis (RSA). - Long-term follow-up IBP prothesis using RSA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Received an IBP total elbow prosthesis between June 2003 and February 2006.
- •- Participated in the study assessing the short-term results of the IBP total elbow prosthesis
- •- Sign informed consent for the proposed study.
排除标准
- 未提供
研究者
相似试验
撤回
不适用
Post-operative longitudinal monitoring of osteochondral defects of the talus with ultrasound after bone marrow stimulation.NL-OMON45273Orthopedie5
招募中
不适用
ong-term follow up study after transplantation of human iPSC-derived dopaminergic progenitors in the treatment of Parkinson's DiseaseParkinson's diseaseJPRN-UMIN000048476Kyoto University Hospital7
已完成
不适用
ong-term follow up after implantation of Artisan Phakic Iris Claw Intraocular lens for the correction of high degree myopiashortsightedness1001591710043413myopiaNL-OMON39608Academisch Medisch Centrum200
尚未招募
不适用
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (TX200-TR101) in a prior clinical study.Renal transplant rejectionAllograft rejection1002766510029149NL-OMON56013Sangamo Therapeutics France SAS8
进行中（未招募）
1 期
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg therapy, TX200-TR101) in a prior clinical study.Prevention of immune mediated allograft rejection in patients with end-stage renal disease (ESRD) who are tissue typed as HLA-A*02 negative and have received a kidney transplant from an HLA-A*02 positive living donor.MedDRA version: 21.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2022-002440-40-DESangamo Therapeutics France SAS15